About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Thursday, May 4th, 2017

The QualityStocks
Daily Stock List


PharmaCyte Biotech, Inc. (PMCB)

OTCJournal, Damn Good Penny Picks, Penny Picks, InvestorPlace, Wall Street Corner, Stock Market Media Group, Goldman Small Cap Research, SmallCapNetwork, Cannabis Financial Network News, BUYINS.NET, MyBestStockAlerts, Darth Trader, Fast Money Alerts, Penny Stock Beats, Penny Stock General, PennyStockInformer, PennyStockLaboratory, Stock Shock and Awe, and The Stock Psycho reported earlier on PharmaCyte Biotech, Inc. (PMCB), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

A clinical stage biotechnology company, PharmaCyte Biotech, Inc. concentrates on developing targeted treatments for cancer and diabetes applying its signature live cell encapsulation technology, Cell-in-a-Box®. This unique and patented technology is being used as a platform upon which treatments for many kinds of cancer, including advanced, inoperable pancreatic cancer, and diabetes are being built. Listed on the OTCQB, PharmaCyte Biotech has its corporate headquarters in Silver Spring, Maryland.

Additionally, the Company is working towards improving the quality of life of patients with advanced pancreatic cancer and on developing treatments for other kinds of solid cancerous tumors. PharmaCyte Biotech’s treatment for pancreatic cancer involves low doses of the recognized anticancer prodrug ifosfamide, together with encapsulated live cells that convert ifosfamide into its active or "cancer-killing" form. These capsules are placed as close to the cancerous tumor as possible. This is to enable the delivery of the highest levels of the cancer-killing drug at the source of the cancer.

Furthermore, PharmaCyte is developing treatments for cancer founded upon chemical constituents of the Cannabis plant, called cannabinoids. The Company is examining ways to exploit the benefits of Cell-in-a-Box® technology in optimizing the anticancer effectiveness of cannabinoids, while minimizing or outright eliminating the debilitating side effects normally associated with cancer treatments.

The live-cell encapsulation technology that PharmaCyte uses is a way to enclose living cells in protective “cocoons” around the size of the head of a pin. The Company encapsulates living cells, not drugs.  Each capsule can enclose about 10,000 cells. This number can vary depending upon the size of the cells encapsulated. PharmaCyte Biotech is advancing its new treatment for pancreatic cancer into the clinic in the United States, with study sites in Europe and Australia.

Last month, PharmaCyte Biotech announced that its research partner, the University of Northern Colorado (UNC), has made major progress with the Company’s Cannabis Research Program. Notable is that a parental cell line identical to that being utilized in PharmaCyte Biotech’s Cell-in-a-Box® + ifosfamide pancreas cancer therapy is being employed to develop a therapy for cancer using cannabinoids as the chemotherapy agent.

Also in April, PharmaCyte Biotech announced that it received the 2017 Buzz of BIO “Pipelines of Promise” award ahead of the 2017 BIO International Convention. Each year BIO International opens voting for its Buzz of BIO award in two categories. One category is “Pipelines of Promise”; the other is “Technologies of Tomorrow.” The winners are announced ahead of BIO International’s annual convention. The BIO International Convention attracts 16,000 biotechnology and pharma leaders. They come together for one week of intensive networking to discover new opportunities and promising partnerships.

PharmaCyte Biotech, Inc. (PMCB), closed Thursday's trading session at $0.066, down 2.80%, on 5,214,666 volume with 217 trades. The average volume for the last 60 days is 2,272,856 and the stock's 52-week low/high is $0.023/$0.1689.

Liquidmetal® Technologies, Inc. (LQMT)

Marketbeat, Jason Bond, Promotion Stock Secrets, Penny Pro, Winston Small Cap, Wall Street Mover, SmallCapVoice, PennyStocks24, Pennybuster, SuperNova Elite, Wealth Daily, PennyStocks Forever, Greenbackers, and Penny Stocks VIP reported earlier on Liquidmetal Technologies, Inc. (LQMT), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Liquidmetal® Technologies, Inc. is the leading developer of bulk alloys that use the performance advantages that amorphous alloy technology provides. Amorphous alloys are unique materials distinguished by their ability to retain a random structure when they solidify. This is versus the crystalline atomic structure that forms in ordinary metals and alloys. Liquidmetal® Technologies is based in Rancho Santa Margarita, California where it also has its Manufacturing Center of Excellence.

Liquidmetal Technologies is the first company to produce amorphous alloys in commercially viable bulk form. This is enabling critical improvements in products across a broad spectrum of industries.

Liquidmetal has two to three times the strength of titanium and stainless steel. It undergoes processing similar to plastics on the Company's proprietary Liquidmetal molding machines. The Company’s class of patented alloys and processes form the basis of high performance materials used in a wide array of medical, military, consumer, and industrial, and sporting goods products. Liquidmetal® Technologies controls the intellectual property (IP) rights with over 70 U.S. patents.   

Liquidmetal is processed and solidified in a vitreous or amorphous state (frozen liquid). Liquidmetal® Technologies’ alloys are, in many cases, stronger, harder, more elastic, and more wear and corrosion resistant than typically used high-performance alloys. The Company’s "bulk" amorphous alloys possess advantages normally associated with plastics. These include the ability to undergo molding into precision, complex, and also highly finished products.

Liquidmetal® Technologies and the University of Southern California’s M.C. Gill Composites Center are working together to develop an advanced manufacturing process to produce large-scale amorphous metal and fiber laminate sheets for space applications. The work is funded by a NASA SBIR (Small Business Innovation Research) Phase I contract addressing solicitation topic number Z2.01, “Cross cutting advanced manufacturing process for large scale bulk metallic glass systems for aerospace applications.”

Recently, Liquidmetal® Technologies announced that it passed additional pre-screening biocompatibility tests for use in medical implants. The Company is presently pursuing collaborations with medical implant companies. This past February, the Company received long-term implantation results from parts 3, 10, 6 and 11 of the ISO 10993 (Biological Evaluation of Medical Devices) family of tests that include evaluation of genotoxicity, sub-chronic systemic toxicity, and pyrogenicity. Liquidmetal® Technologies’ alloy LM105 passed all of these tests well within the allowable limits.

Last month, Liquidmetal® Technologies announced that it received two hot crucible amorphous metal molding machines from its licensing partner Eontec Ltd. The machines permit the production of amorphous alloy parts that are up to three times larger and one-third the cost of established technologies.

Liquidmetal Technologies, Inc. (LQMT), closed Thursday's trading session at $0.2902, up 2.54%, on 1,909,463 volume with 316 trades. The average volume for the last 60 days is 1,460,714 and the stock's 52-week low/high is $0.1179/$0.295.

Walker Innovation, Inc. (WLKR)

Marketbeat and Wall Street Mover reported on Walker Innovation, Inc. (WLKR), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Walker Innovation, Inc. is an innovation services enterprise that helps companies improve their internal product and business development efforts. In addition, the Company owns a portfolio of its own intellectual property (IP). Walker Innovation looks to commercialize, license, and enforce the innovative portfolio of IP developed by inventor and entrepreneur, Mr. Jay Walker, who serves as Walker Innovation’s Executive Chairman. Mr. Walker is best known as the Founder of Priceline.com.

Walker Innovation was incorporated in the State of Delaware in January 2002. Walker Innovation has its headquarters in Stamford, Connecticut. The Company formerly went by the name Patent Properties, Inc. It changed its corporate name to Walker Innovation, Inc. in July 2015.

The Company’s Licensing and Enforcement division grants IP rights for the use of or concerning, patented technologies. This division monetizes its IP via the sale of select patent assets. Walker Innovation’s patent portfolio comprises 400 granted patents, and roughly 60 pending patent applications. The Licensing and Enforcement division’s patents describe inventions in areas including authentication techniques, Internet search, social networking, advertising, online transactions, and others.

In February 2017, Walker Innovation announced Q4 and full year 2016 results. For Q4 2016, it recorded a realized gain of about $7.1 million in connection with its exercise and sale of 3.75 million shares associated with its warrant to acquire shares of The Upside Commerce Group, LLC, a new business travel service founded and launched by Mr. Jay Walker.

Moreover, the Company recorded a non-cash, unrealized gain of roughly $7.6 million in connection with the ownership of its warrant to acquire shares of The Upside Commerce Group. Walker Innovation still holds a warrant to purchase 12.65 million shares of Upside.

Walker Innovation recognized Revenue of roughly $1.9 million during Q4 of 2016 versus $2.0 million for Q4 of 2015. It reported Net Income for Q4 of 2016 of $15.4 million, or $0.43 per share on a diluted basis, versus a net loss of $0.4 million, or a loss per share of $0.02, in the prior-year period.

Walker Innovation, Inc. (WLKR), closed Thursday's trading session at $0.35, down 1.41%, on 99,994 volume with 15 trades. The average volume for the last 60 days is 54,377 and the stock's 52-week low/high is $0.213/$0.70.

TSS, Inc. (TSSI)

Marketbeat, RedChip, and Wall Street Resources reported earlier on TSS, Inc. (TSSI), and we highlight the Company today, here at the QualityStocks Daily Newsletter.

TSS, Inc. is a data center and mission critical facilities and technology services enterprise. The Company is a single source provider of mission-critical planning, design, system integration, deployment, maintenance, and development of data centers facilities and information infrastructure. TSS is an innovator in the hyper-dynamic mission-critical facilities industry. The Company has its corporate headquarters in Round Rock, Texas. TSS lists on the OTCQB.

The Company has worked across many industries. TSS has planned, designed, built, and also maintained specialized facilities. These include data centers, communications rooms, SCIFs, call centers, laboratories, trading floors, network operations centers, and medical facilities.

TSS provides a single-source solution for mission-critical facilities. It specializes in customizable end-to-end solutions powered by industry experts and creative services. These include technology consulting, engineering, design, project management, operations, facilities management, technology system installation and integration, and maintenance for traditional and modular data centers.

TSS is an innovator and leader in mission-critical infrastructure design and support services. These include Modular Data Centers, Assessments & Audits, Design & Budgeting, Project & Construction Services, Operations & Maintenance, and Planning & Analysis or Transformation Services. Its Data Center Services include Modular Data Centers; Data Center Health Check; Facility Assessment; Owners Representation; Strategic Options Analysis; CFD Assessment; Data Center Transition Planning; IT Equipment Relocation Services; and Arc Flash-Hazard Analysis.

TSS integrates a facility’s electrical, mechanical, security, and building envelope into a unified strategic asset. Its aim is to provide its customers with the most advanced and reliable mission-enabling solutions. TSS’s expertise is in Information Technology (IT) and integrated facilities services.

Last month, TSS reported results for its Q4 and fiscal year ended December 31, 2016.  The Company had Q4 2016 revenue of $7.3 million versus $10.1 million in Q4 2015 and $5.4 million in Q3 of 2016. It had Gross Margin of 31 percent in Q4 of 2016 versus 25 percent in Q4 of 2015. Furthermore, it had Net Income of $148,000 or $0.01 per share, versus a Net Income of $16,000 or $(0.00) per share in Q4 of 2015.

Fiscal Year highlights include 2016 Revenue of $27.4 million versus $29.5 million in 2015. The Company had Gross Profit Margin of 26 percent in 2016 versus 28 percent in 2015. TSS had a Net Loss of $1.0 million or $(0.07) per share, versus a net loss of $2.2 million or $(0.15) per share the year prior.

TSS, Inc. (TSSI), closed Thursday's trading session at $0.21161, down 2.93%, on 148,745 volume with 87 trades. The average volume for the last 60 days is 236,932 and the stock's 52-week low/high is $0.04/$0.40.

Scientific Metals Corp. (SCTFF)

We are reporting on Scientific Metals Corp. (SCTFF) today, here at the QualityStocks Daily Newsletter.

Headquartered in Vancouver, British Columbia, Scientific Metals Corp. is an exploration enterprise centered on the acquisition and development of production grade metal deposits, which are vital components to contemporary rechargeable batteries. The Company’s key assets are in Idaho, Utah, and Alberta. Scientific Metals lists on the OTC Markets Group’s OTCQB.

The Company has its Paradox Basin Lithium Brine Property. This Property comprises 111 mineral claims encompassing about 2,220 acres, which contain eight historic oil and gas drill holes. The Paradox Property is roughly 4 kilometers’ northwest of Intrepid Potash’s Cane Creek Operation and is contiguous to the north of Voltaic Minerals Corp.'s "Green Energy" lithium property.

Scientific Metals also has its Iron Creek Cobalt Property (Lemhi County, Idaho). The Iron Creek Cobalt Property is along the most prolific trend of cobalt mineralization in the United States, the Idaho Cobalt Belt. This Property benefits from a considerable amount of historical exploratory work. This includes around 30,000 feet of diamond drilling and the mining of 1,500 feet of underground workings.

In the Province of Alberta, the Company has its Deep Valley Lithium Property. This Property is in the Fox Creek - Sturgeon Lake area of west-central Alberta. The Deep Valley Lithium Property covers 6,648 ha (16,427 acres) and is roughly 55 kilometers due west of the community of Fox Creek.

In Q1 2017, Scientific Metals completed a $3.5M financing expected to completely fund the Company for its 2017 work program at its Iron Creek cobalt project. In addition, the Company compiled and processed the exploration data resulting from 30,000 feet of historical drilling. The data was provided by previous operators at Iron Creek - Cominco, Hanna Mining, and Noranda.

Furthermore, the petro-lithium joint venture with MGX Minerals was completed. Scientific Metals’ interest is fully carried for the upcoming year which gives it exposure to this new project, while allowing it to allocate its resources fully on the Iron Creek cobalt property.

Furthermore, the Iron Creek project land package increased by 500 acres in Q1 2017. Also, mining and drilling contractors were hired. In April, Scientific Metals announced that it launched its 2017 exploration program at the Iron Creek Cobalt Project, initially starting with the rehabilitation of the underground workings.

Scientific Metals Corp. (SCTFF), closed Thursday's trading session at $0.732, down 10.58%, on 404,848 volume with 223 trades. The average volume for the last 60 days is 112,918 and the stock's 52-week low/high is $0.1228/$0.88.


The QualityStocks
Company Corner


InMed Pharmaceuticals, Inc. (IMLFF)

The QualityStocks Daily Newsletter would like to spotlight InMed Pharmaceuticals, Inc. (IMLFF). Today, InMed Pharmaceuticals, Inc. closed trading at $0.411, up 9.78%, on 748,727 volume with 339 trades. The stock’s average daily volume over the past 60 days is 1,168,749, and its 52-week low/high is $0.05/$0.72.

InMed Pharmaceuticals, Inc. (IMLFF) is a preclinical-stage biopharmaceutical company specializing in the development of novel therapeutics leveraging the pharmacological benefits of cannabinoids. Utilizing its proprietary bioinformatics assessment tool, InMed aims to identify bioactive compounds found within the cannabis plant that have the potential to offer optimized therapeutic benefit while demonstrating limited adverse effects. This assessment tool, in combination with the company’s cannabinoid biosynthesis technology and drug development pipeline, serves as InMed’s fundamental value driver.

Bioinformatics is a proprietary, computer-based program designed to assist in the identification of novel cannabinoids using comprehensive algorithms to integrate data from numerous bioinformatics databases, as well as a database on the structure of currently approved pharmaceutical products and an extensive database on over 90 individual cannabinoid drugs found in cannabis. This extensive collection of data is derived from both public and propriety-based sources. Leveraging this tool, the company aims to create associations between approved pharmaceuticals and cannabinoids with similar structures in order to identify active cannabinoids that have the potential to treat specific diseases. Per InMed’s website, this type of bioinformatics assessment represents “significant promise for future drug discovery, as it integrates many data sets and builds holistic models to approach a specific disease.”

After discovering these promising active cannabinoids, InMed moves to test and confirm their activity in biological systems through in vitro and in vivo experimentation. It is at this stage of development that the company’s proprietary biosynthesis process of cannabinoid manufacturing will be most promising. InMed is currently developing a robust, high-yield biosynthesis process for manufacturing all 90+ naturally-occurring cannabinoids. By modifying the agriculture-based formula for harvesting cannabinoids, InMed aims to combine the inherent safety and known efficacy of the natural drug structure with the convenience, control and quality of 21st Century laboratory-based manufacturing processes.

The company’s pipeline currently includes two drug candidates in preclinical development, including INM-750 for the treatment of epidermolysis bullosa (EB) and INM-085 for the treatment of glaucoma. Referred to by the Dystrophic Epidermolysis Bullosa Research Association of America as “The Worst Disease You’ve Never Heard Of,” EB is a rare genetic connective tissue disorder that affects roughly one out of every 20,000 births in the United States. The condition currently has no approved treatment or cure. Through the development of INM-750, InMed is attempting to address this significant unmet medical need. The drug candidate replaces missing keratins in the skin with specially selected cannabinoids in an effort to modulate the painful manifestations of EB.

INM-085, InMed’s second development candidate, is formulated to reduce the elevated intra-ocular pressure that is often associated with glaucoma. Additionally, the cannabinoids utilized in INM-085 are expected to provide neuroprotection for the retinal ganglion cells and other optic nerve tissues following topical administration. Although it is still in preclinical development, INM-085 targets a sizable market. According to the Glaucoma Research Foundation, glaucoma is a leading cause of blindness with no approved cure. The National Institutes of Health estimates that more than 3 million Americans currently have glaucoma, and more than 120,000 have been blinded by the disease.

InMed is focused on progressing toward validation of its drug candidate selection, using data to secure its patents and developing key disruptive technologies. In 2016, the company was successful in completing financings of $1.9 million. In January 2017, InMed completed a non-brokered private placement of common shares generating aggregate gross proceeds of C$1.5 million, strongly positioning the company to attract the new investment required to fund its aggressive growth strategies in 2017.

The company’s management team has well over a century of combined experience in the biopharmaceutical space. Company CEO Eric Adams has more than 25 years of experience in company and capital formation, global market development, mergers and acquisitions, licensing and corporate governance. During his time as CEO of enGene Inc., he led the gene therapy startup to a position at the head of the industry.

Joining Adams on the InMed management team are Chief Scientific Officer Dr. Sazzan Hossain; Senior Vice President, Clinical and Regulatory Affairs Alexandra D.J. Mancini; SVP, Corporate Strategy & Investor Relations Chris Bogart; and Chief Financial Officer Jeff Charpentier, as well as Chief Medical Officer Dr. Ado Muhammed, MD, DPM, MFPM.

Muhammed, in particular, has an extensive history in the pharmaceutical industry, having previously served as an executive of GW Pharmaceuticals, a global leader in the development of cannabinoid-based medicines. During his time as Associate Medical Director of that company, Muhammed played an instrumental role in the development and FDA approval of one of the first cannabis drugs. This GW Pharmaceuticals development program coincided with a sharp rise in share price from less than $9 in 2013 to more than $129 today, with the company’s current market value totaling more than $2.9 billion. Disclaimer

InMed Pharmaceuticals, Inc. Company Blog

InMed Pharmaceuticals, Inc. News:

InMed Pharmaceuticals' Unique Approach Featured in Forbes -- CFN Media

InMed's Exceptional Management Team Executes Ambitious Plan -- CFN Media

NetworkNewsWire Announces Publication of Discussion on the R&D of Cannabinoids for Medical Use

Singlepoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight Singlepoint, Inc. (SING). Today, Singlepoint, Inc. closed trading at $0.0475, up 6.03%, on 3,917,856 volume with 235 trades. The stock’s average daily volume over the past 60 days is 6,457,056, and its 52-week low/high is $0.0058/$0.142.

Singlepoint, Inc. (SING) provides mobile technology and marketing solutions that enable companies, nonprofits and religious organizations to conduct business transactions, accept donations, and engage in targeted communication via mobile devices. Through diversification of its own model, the company is also leveraging its core technology to expand into the mobile auctions and daily fantasy sports markets.

SING currently has two fundraising solutions. Text2Bid is an interactive way to increase auction revenues. The technology makes it easy for people to bid in auctions from any text or web-enabled phone. Donate by Text allows nonprofits to securely collect one-time or recurring donations via text. This capability creates a personal experience for the donors, and enables ongoing communication between the donor and nonprofit or event sponsor.

SING's payment solutions include point-of-sale (POS) terminals, loyalty programs, payment processing, phone services and financing. Pay by Text™ enables a business to accept payment transactions and, in essence, turns the user's mobile phone into a point-of-sale device. Operating on the same platform as mobile marketing, Pay by Text is designed to increase revenues, raise the average per-transaction amount, and create a fast, easy and hassle-free method of payment.

As part of its diversification and expansion strategy, SING recently acquired an interest in DraftFury (www.draftfury.com), a company that offers skill-based NBA, NFL and MLB daily fantasy sports (DFS) contests. DraftFury is known for its innovative offerings and originality, and is the first cash-flow-positive DFS enterprise. This transaction places SING in a multi-billion dollar industry expected to generate entry fees of $14.4 billion in 2020. Under the guidance of a leadership team well-versed in technology, engineering, marketing and raising capital, SING anticipates a strong foothold in its chosen markets. Disclaimer

Singlepoint, Inc. Company Blog

Singlepoint, Inc. News:

SinglePoint, Inc. Updates Shareholders on Initiatives to Strengthen Corporate Value

NetworkNewsWire Announces Publication on Various Companies Involved in Booming Cannabis Industry, Including Singlepoint

SinglePoint Draws Attention as Near-term Catalysts Approach -- CFN Media

Grey Cloak Tech, Inc. (GRCK)

The QualityStocks Daily Newsletter would like to spotlight Grey Cloak Tech, Inc. (GRCK). Today, Grey Cloak Tech, Inc. closed trading at $0.0715, up 2.14%, on 5,000 volume with 1 trade. The stock’s average daily volume over the past 60 days is 98,898, and its 52-week low/high is $0.025/$0.64.

Grey Cloak Tech, Inc. (GRCK) is a developer of industry-leading click-fraud detection software designed to overcome the most expensive and devastating threats in the digital world. Through its recently acquired subsidiary, ShareRails, Grey Cloak now also provides sophisticated e-commerce tools that help retailers evolve beyond their brick-and-mortar business practices to increase both their digital engagement and their foot traffic.

ShareRails is an online-to-offline technology firm that provides vitally important services within the trillion-dollar retail sector, helping brick-and-mortar retailers compete directly for online awareness with e-commerce-only brands. Through the ShareRails O2O platform, offline retailers can use online channels to more effectively drive sales and attract new customers.

The innovative solutions offered by ShareRails enable local retailers to capture the millions of online shopping searches they are currently missing out on because their product inventories and other key information is not currently available online and, therefore, does not appear in relevant searches and cannot be viewed digitally.

Most of today's retail sales are Web-influenced. By utilizing digital marketing channels, merchants can enhance the in-store shopping experience for customers and simultaneously boost sales. The ShareRails O2O platform enables retailers to put their product catalogs online, along with product location and availability, and make the information searchable. The platform also offers digital merchandising tools that include an outfit builder and wishlist app along with conversational shopping tools. Through ShareRails O2O, merchants can additionally tap into data that details shopper insights and behavioral trends. Add-on services include click-n-collect, reservations for in-store pickup, and local delivery.

ShareRails additionally offers Dress.li, which is a recommendation and reward platform that connects shoppers to stylists, bloggers and other fashion influencers who provide them with expert shopping advice and uniquely styled looks and, simultaneously, connects the consumers to fashion retailers. Through Dress.li, the challenge of creating a seamless social shopping experience has finally been mastered! This platform facilitates live shopping communications, curation and content creation and lets users join a global network of trendsetters. Through this network, users can inspire and be inspired, accessing and sharing product recommendations and unique looks and receiving rewards each time another user makes a purchase from their recommendations. This platform not only provides an enjoyable and exciting network for shoppers and fashionistas, but it simultaneously supplies retailers with a lucrative outlet for acquiring new customers through a built-in global sales force of fashion influencers. As these Dress.li stylists create and share looks, they also deliver pre-qualified sales leads and conversions and are rewarded for doing so.

Joined together, Grey Cloak Tech's industry-leading click-fraud detection solutions and the exciting retail-boosting products delivered through ShareRails offer a broad package of services to both protect businesses in the digital world and help them utilize digital channels to bolster their sales and enhance customer engagement.

Grey Cloak Tech continues to serve as an industry leader in developing the most effective and comprehensive weapons to fight online security threats. The company is keenly focused on protecting its clients' interests through the identification of fraud patterns at the very earliest stages. When businesses partner with Grey Cloak Tech, they can look forward to benefiting from industry-leading technology, a top-tier client services team, and an augmented bottom line. Disclaimer

Grey Cloak Tech, Inc. Company Blog

Grey Cloak Tech, Inc. News:

Grey Cloak Tech's ShareRails Launches first Searchable Mall for Pacific Retail Capital Partners, Allowing Consumers to Find Online and Buy In Store

Grey Cloak Tech Completes the Acquisition of ShareRails O2O E-commerce Services Platform

Grey Cloak Tech, Inc. (GRCK) is “One to Watch”

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX). Today, ChineseInvestors.com closed trading at $1.13, up 0.89%, on 13,049 volume with 27 trades. The stock’s average daily volume over the past 60 days is 85,125 and its 52-week low/high is $0.12/$2.75.

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world's first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer's disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX's cannabis-focused "Yelp"-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. Disclaimer

ChineseInvestors.com Blog

ChineseInvestors.com News:

ChineseInvestors.com, Inc. Appoints Summer Yun as CEO of CBD Biotechnology Co., Ltd., Wholly-owned Foreign Entity

Consilium Global Research Issues Executive Summary on Chinese Investors.com, Inc. (OTCQB: CIIX)

ChineseInvestors.com, Inc. Announces 3Q Financial Results, Posts Nearly 100% YoY Increase, Expects Hemp Products to Generate Substantial Revenues in 2018

National Waste Management Holdings, Inc. (NWMH)

The QualityStocks Daily Newsletter would like to spotlight National Waste Management Holdings, Inc. (NWMH). Today, National Waste Management Holdings, Inc. closed trading at $0.1025, up 0.49%, on 53,941 volume with 6 trades. The stock’s average daily volume over the past 60 days is 20,992, and its 52-week low/high is $0.06/$0.41.

National Waste Management Holdings, Inc. (NWMH) is a solid waste management company offering comprehensive solutions for full waste diversion along Florida's west coast and in upstate New York. With an established base of long-term partnerships with municipal, institutional, commercial and industrial customers, along with a successful acquisition strategy, National Waste has set its course to become a leading waste diversion company.

National Waste's 54-acre landfill facility located in Hernando, Florida, handles annual average disposals of roughly 240,000 cubic yards of construction debris annually. The site also offers an array of ancillary services such as roll-off dumpster services, mulching services and recycling. While the landfill facility is already permitted for future expansion, National Waste's growth strategy also calls for the opening of new satellite offices in counties and states that neighbor its existing operations.

In addition to increasing its geographic foothold, National Waste employs a strategic acquisition model to increase its overall market share. In 2015, the company acquired Gateway Rolloff Services LP and Waste Recovery Enterprises LLC, which are expected to generate a combined $3.8 million in annual revenue for National Waste moving forward. In the second quarter of 2016, National Waste added Sivart Services to its roster, creating an immediate source of additional revenue and expanding its foothold in the northeast area of New York.

Management has confirmed its interest in additional acquisition targets while demonstrating its ability to effectively integrate and organically grow the company's existing acquisition companies and maintain efficient operations. Disclaimer

National Waste Management Holdings, Inc. Company Blog

National Waste Management Holdings, Inc. News:

National Waste Management Holdings Inc. Reports Full-Year 2016 Results, Triple-Digit Revenue Growth

National Waste Management Holdings, Inc. Expands Territory with Acquisition of Burts Refuse, LLC

National Waste Management Holdings, Inc. (NWMH) Expands Market Reach in New York with Acquisition of Northeast Data Destruction and Recycling


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters



(NHLDW) +177.30%


MarketClub Analysis
(APHB) +62.92%


Trader Power News
(CDNA) +35.63%

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251